Great Valley Advisor Group, Inc. Biocryst Pharmaceuticals Inc Transaction History

Great Valley Advisor Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$4.13 - $6.79 $4,130 - $6,790	-1,000 Reduced 5.75%	16,400 $101,000
Q1 2024 May 03, 2024	BUY	$4.89 - $7.65 $5,379 - $8,415	1,100 Added 6.75%	17,400 $88,000
Q3 2023 Nov 06, 2023	BUY	$6.71 - $7.92 $28,182 - $33,264	4,200 Added 34.71%	16,300 $115,000
Q2 2023 Aug 10, 2023	BUY	$6.96 - $8.81 $12,528 - $15,858	1,800 Added 17.48%	12,100 $85,000
Q1 2023 May 02, 2023	BUY	$7.94 - $11.84 $81,782 - $121,952	10,300 New	10,300 $85,000

277

167M

728K

989K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.46B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.